Formulation Development White Papers & Articles
-
Ready To Demystify Organoids?
7/1/2025
Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.
-
Efficiently Select Your Antibody Or Antibody Variant Purification Strategy
7/1/2025
Explore the evolution of antibody therapeutics from monoclonal antibodies to next-gen formats and discover innovative strategies for purifying these complex molecules in today’s landscape.
-
Efficiently Select And Optimize Antibody Candidates
7/1/2025
Discover how innovative systems streamline antibody development to enhance target-binding analysis, optimize therapeutic selection, and accelerate clinical success with precision tools.
-
Streamline Your Pathway To IND With A Rapid Tox Approach
6/26/2025
With tox material in hand as soon as possible, antibody-derived drug developers can conduct their tox studies earlier, facilitating a timely IND submission and speeding up pathways to patients.
-
Experimental Pain Models — SNL Model Of Neuropathic Pain
6/20/2025
Explore how a validated Spinal Nerve Ligation (SNL) model enables effective preclinical evaluation of novel analgesics for neuropathic pain.
-
Quicker Development Using Cell Line Integration, End-To-End Support
6/19/2025
Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.
-
Experimental CCI — Induced Neuropathic Pain Model
6/18/2025
Advance neuropathic pain research and therapeutic development with the Chronic Constriction Injury (CCI)-induced neuropathic pain model to uncover mechanisms and evaluate promising candidates.
-
Manufacturing CAR T Cell Therapies: Challenges, Insights And Solutions
6/16/2025
Manufacturing patient-specific cell therapies is a complex, multi-step process. Addressing key hurdles in production time, scalability, and cost is crucial to making these vital treatments more accessible.
-
Preclinical Evaluation Of Vaccines And Antivirals In RSV Challenge Rodent Models
6/10/2025
Here, we present multiple case studies utilizing clinically relevant mouse and rat models to evaluate key characteristics of potential RSV therapeutics.
-
Preclinical Evaluation Of New Antifibrotics In NASH-Induced Fibrosis Models
6/10/2025
Accelerate the development of antifibrotic therapies through our clinically relevant models, deep scientific expertise, and proven preclinical capabilities in this area of unmet medical need.